Tomas Jelinek
0000-0002-5467-9253
Clinica Universitaria de Navarra
3 papers found
Refreshing results…
FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14)
Missing publications? Search for publications with a matching author name.